Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Mark S Gold

Biographic Data

ID4489267
NAMEMark S Gold
GIVEN NAMESMark S
FAMILY NAMEGold
SIGNATUREGOLD M S
AFFILIATIONSWashington University in St. Louis
ORCID0000-0003-4713-3751
VERIFIEDYes
TOTAL WORKS23
TOTAL CITATIONS3
WORKS AS AUTHOR23
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1972
LATEST PUBLICATION YEAR2026
H-INDEX1
  • The Emerging Crisis in Non-Prescribed Ketamine Use

    Open Access•Kai Uwe Lewandrowski, Kenneth Blum et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: Since 2000, rates of suicide and opioid overdose have sharply increased. Approximately one-third of individuals with major depressive disorder (MDD) experience treatment-resistant depression (TRD), highlighting the urgent need for novel therapeutic approaches. OBJECTIVE: This review synthesizes pivotal preclinical and clinical findings on low-dose ketamine's rapid antidepressant effects and examines proposed mechanisms underlying its …

  • Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

    Open Access•Kai-Uwe Lewandrowski, Kenneth Blum et al.•ARTICLE•Frontiers in Public Health•2025

    Since 1990, substantial evidence from association studies has identified the D(2) dopamine receptor (DRD2) gene as a factor in the development of alcoholism [1][2][3][4]. The DRD2 gene has also been linked to other substance use disorders, including dependencies on cocaine, nicotine, and opioids, as well as obesity [5][6][7][8][9][10][11]. Dopamine in the brain, often referred to as the "stressrelief molecule," plays a central role in managing st…

  • Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery

    Open Access•Colin Hanna, Fiona Comstock et al.•ARTICLE•Frontiers in Public Health•2025

    The obesity epidemic has become a global public health issue, impacting more than one billion people worldwide. 9% of the US population, or 28.8 million Americans will have an eating disorder in their lifetime. In fact, global eating disorder prevalence increased from 3.5% to 7.8% between 2000 and 2018. In spite of the fact that less than 6% of people with an eating disorder are medically underweight, it is indeed an important factor when conside…

  • Opioid use disorder

    Open Access•Yu Kyung Lee, Mark S Gold et al.•ARTICLE•Frontiers in Public Health•2024

    Opioid use disorder (OUD) is a major public health threat, contributing to morbidity and mortality from addiction, overdose, and related medical conditions. Despite our increasing knowledge about the pathophysiology and existing medical treatments of OUD, it has remained a relapsing and remitting disorder for decades, with rising deaths from overdoses, rather than declining. The COVID-19 pandemic has accelerated the increase in overall substance …

  • High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling

    Open Access•John Tyler, Madeline Podaras et al.•ARTICLE•Frontiers in Public Health•2023

    Background Previous research has outlined the health benefits of exercise including its therapeutic potential for substance use disorders (SUD). These data have already been utilized and it is now common to find exercise as part of SUD treatment and relapse prevention programs. However, we need to better understand different exercise regimens and determine which would be the most beneficial for SUDs. Recently, high intensity interval training (HI…

  • Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (Gars) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic…

    Open Access•Ashim Gupta, Abdalla Bowirrat et al.•ARTICLE•International Journal of…•2022

    In the United States, amid the opioid overdose epidemic, nonaddicting/nonpharmacological proven strategies are available to treat pain and manage chronic pain effectively without opioids. Evidence supporting the long-term use of opioids for pain is lacking, as is the will to alter the drug-embracing culture in American chronic pain management. Some pain clinicians seem to prefer classical analgesic agents that promote unwanted tolerance to analge…

  • Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans

    Open Access•Kenneth Blum, Jag Khalsa et al.•ARTICLE•Frontiers in Psychiatry•2021

    Over years, the regular use of cannabis has substantially increased among young adults, as indicated by the rise in cannabis use disorder (CUD), with an estimated prevalence of 8. 3% in the United States. Research shows that exposure to cannabis is associated with hypodopaminergic anhedonia (depression), cognitive decline, poor memory, inattention, impaired learning performance, reduced dopamine brain response-associated emotionality, and increas…

  • Reward Deficiency Syndrome (RDS)

    Open Access•Kenneth Blum, Abdalla Bowirrat et al.•ARTICLE•International Journal of…•2021

    Alcohol and other substance use disorders share comorbidity with other RDS disorders, i.e., a reduction in dopamine signaling within the reward pathway. RDS is a term that connects addictive, obsessive, compulsive, and impulsive behavioral disorders. An estimated 2 million individuals in the United States have opioid use disorder related to prescription opioids. It is estimated that the overall cost of the illegal and legally prescribed opioid cr…

  • Putative Covid- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion

    Kenneth Blum, Jean Lud Cadet et al.•ARTICLE•Substance Use & Misuse•2020

  • Preclinical evidence for the addiction potential of highly palatable foods

    Open Access•David A Wiss, Kristen Criscitelli et al.•ARTICLE•Appetite•2017•Cited by: 2•References: 104

  • Food consumption and weight gain after cessation of chronic amphetamine administration

    Caitlin A Orsini, Guy Ginton et al.•ARTICLE•Appetite•2014•Cited by: 1•References: 52

  • Biomarkers in psychiatry

    Open Access•Firas Kobeissy, Ali Alawieh et al.•ARTICLE•Frontiers in Psychiatry•2013

    GENERAL COMMENTARY article Front. Psychiatry, 07 January 2013Sec. Molecular Psychiatry https://doi.org/10.3389/fpsyt.2012.00114

  • Sex, Drugs, and Rock ‘N’ Roll

    Kenneth Blum, Tonia Werner et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    The nucleus accumbens, a site within the ventral striatum, plays a prominent role in mediating the reinforcing effects of drugs of abuse, food, sex, and other addictions. Indeed, it is generally believed that this structure mandates motivated behaviors such as eating, drinking, and sexual activity, which are elicited by natural rewards and other strong incentive stimuli. This article focuses on sex addiction, but we hypothesize that there is a co…

  • Food Addiction and Obesity

    Yijun Liu, Karen M von Deneen et al.•ARTICLE•Journal of Psychoactive Drugs•2010

    Obesity has become a major health problem and epidemic. However, much of the current debate has been fractious and etiologies of obesity have been attributed to eating behavior or fast food, personality issues, depression, addiction, or genetics. One of the interesting new hypotheses for epidemic obesity is food addiction, which is associated with both substance-related disorder and eating disorder. Accumulating evidences have shown that there ar…

  • The encyclopedia of alcoholism and alcohol abuse

    Mark S Gold•BOOK•The encyclopedia of alcoholism…•2010

  • Is Speeding a Form of Gambling in Adolescents

    Open Access•David S Husted, Mark S Gold et al.•ARTICLE•Journal of Gambling Studies•2006

  • Can Drug Design Inhibit Abuse

    John J Coleman, Peter B Bensinger et al.•ARTICLE•Journal of Psychoactive Drugs•2005

    A recent federal report indicates that prescription drug abuse is now the second leading category of illicit drug use, following marijuana use. Control strategies typically focus on reducing the diversion of prescription drugs from legitimate sources. The proliferation of unregulated Internet sources, however, has rendered control strategies less effective. This study examines a new approach that focuses on reducing abusability through the use of…

  • A Neurochemical Basis for Alcohol and Other Drug Addiction

    Norman S Miller, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1993

    There are major clinical observations in alcohol and other drug addicts and neurochemical studies in animals and humans that support the hypothesis for a common neurochemical basis for alcohol and other drug addiction. The common occurrence of concurrent alcohol and multiple drug dependence in clinical and general populations, family history and genetic studies, and basic and clinical research in the neurochemistry of addictive behavior provide e…

  • Benzodiazepines

    Norman S Miller, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1990

    Many recent studies have clearly documented the development of tolerance, dependence, and addiction to benzodiazepines. In spite of these studies and reviews of the literature, confusion remains regarding the risk and benefits of the use of benzodiazepines in medical practice. The source of the confusion arises in part from the lack of clarity in the definitions of tolerance, dependence, and addiction. The distinctions among these important terms…

  • Pharmacological Adjuncts in the Treatment of Opioid and Cocaine Addicts

    Peter Herridge, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1988

    Addiction consists of a complex neuropharmacologic behavioral cycle. The positive reinforcement of the drug and the negative reinforcement of withdrawal serve to drive the behavior of obtaining and ingesting the drug. The pharmacological adjuncts that are available today work by interfering with one or another part of the cycle. The alpha 2-adrenergic agonists, such as clonidine and guanabenz, act to block noradrenergic activity in the locus coer…

  • Methadone Induced Hypoadrenalism

    Open Access•Charles A Dackis, Manuel Gurpegui et al.•ARTICLE•The Lancet•1982

  • Autism and attention

    Open Access•Mark S Gold, Janice R Gold•ARTICLE•Child Psychiatry & Human…•1975

  • An individualized 24-hour therapeutic approach to a psychotic child

    Open Access•Mark S Gold, R H V Ollendorff et al.•ARTICLE•Child Psychiatry & Human…•1972

  • Preclinical evidence for the addiction potential of highly palatable foods

    Open Access•David A Wiss, Kristen Criscitelli et al.•ARTICLE•Appetite•2017•Cited by: 2•References: 104

  • Food consumption and weight gain after cessation of chronic amphetamine administration

    Caitlin A Orsini, Guy Ginton et al.•ARTICLE•Appetite•2014•Cited by: 1•References: 52

  • An individualized 24-hour therapeutic approach to a psychotic child

    Open Access•Mark S Gold, R H V Ollendorff et al.•ARTICLE•Child Psychiatry & Human…•1972

  • Autism and attention

    Open Access•Mark S Gold, Janice R Gold•ARTICLE•Child Psychiatry & Human…•1975

  • Methadone Induced Hypoadrenalism

    Open Access•Charles A Dackis, Manuel Gurpegui et al.•ARTICLE•The Lancet•1982

  • Pharmacological Adjuncts in the Treatment of Opioid and Cocaine Addicts

    Peter Herridge, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1988

    Addiction consists of a complex neuropharmacologic behavioral cycle. The positive reinforcement of the drug and the negative reinforcement of withdrawal serve to drive the behavior of obtaining and ingesting the drug. The pharmacological adjuncts that are available today work by interfering with one or another part of the cycle. The alpha 2-adrenergic agonists, such as clonidine and guanabenz, act to block noradrenergic activity in the locus coer…

  • Benzodiazepines

    Norman S Miller, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1990

    Many recent studies have clearly documented the development of tolerance, dependence, and addiction to benzodiazepines. In spite of these studies and reviews of the literature, confusion remains regarding the risk and benefits of the use of benzodiazepines in medical practice. The source of the confusion arises in part from the lack of clarity in the definitions of tolerance, dependence, and addiction. The distinctions among these important terms…

  • A Neurochemical Basis for Alcohol and Other Drug Addiction

    Norman S Miller, Mark S Gold•ARTICLE•Journal of Psychoactive Drugs•1993

    There are major clinical observations in alcohol and other drug addicts and neurochemical studies in animals and humans that support the hypothesis for a common neurochemical basis for alcohol and other drug addiction. The common occurrence of concurrent alcohol and multiple drug dependence in clinical and general populations, family history and genetic studies, and basic and clinical research in the neurochemistry of addictive behavior provide e…

  • Can Drug Design Inhibit Abuse

    John J Coleman, Peter B Bensinger et al.•ARTICLE•Journal of Psychoactive Drugs•2005

    A recent federal report indicates that prescription drug abuse is now the second leading category of illicit drug use, following marijuana use. Control strategies typically focus on reducing the diversion of prescription drugs from legitimate sources. The proliferation of unregulated Internet sources, however, has rendered control strategies less effective. This study examines a new approach that focuses on reducing abusability through the use of…

  • Is Speeding a Form of Gambling in Adolescents

    Open Access•David S Husted, Mark S Gold et al.•ARTICLE•Journal of Gambling Studies•2006

  • Food Addiction and Obesity

    Yijun Liu, Karen M von Deneen et al.•ARTICLE•Journal of Psychoactive Drugs•2010

    Obesity has become a major health problem and epidemic. However, much of the current debate has been fractious and etiologies of obesity have been attributed to eating behavior or fast food, personality issues, depression, addiction, or genetics. One of the interesting new hypotheses for epidemic obesity is food addiction, which is associated with both substance-related disorder and eating disorder. Accumulating evidences have shown that there ar…

  • The encyclopedia of alcoholism and alcohol abuse

    Mark S Gold•BOOK•The encyclopedia of alcoholism…•2010

  • Sex, Drugs, and Rock ‘N’ Roll

    Kenneth Blum, Tonia Werner et al.•ARTICLE•Journal of Psychoactive Drugs•2012

    The nucleus accumbens, a site within the ventral striatum, plays a prominent role in mediating the reinforcing effects of drugs of abuse, food, sex, and other addictions. Indeed, it is generally believed that this structure mandates motivated behaviors such as eating, drinking, and sexual activity, which are elicited by natural rewards and other strong incentive stimuli. This article focuses on sex addiction, but we hypothesize that there is a co…

  • Biomarkers in psychiatry

    Open Access•Firas Kobeissy, Ali Alawieh et al.•ARTICLE•Frontiers in Psychiatry•2013

    GENERAL COMMENTARY article Front. Psychiatry, 07 January 2013Sec. Molecular Psychiatry https://doi.org/10.3389/fpsyt.2012.00114

  • Food consumption and weight gain after cessation of chronic amphetamine administration

    Caitlin A Orsini, Guy Ginton et al.•ARTICLE•Appetite•2014•Cited by: 1•References: 52

  • Preclinical evidence for the addiction potential of highly palatable foods

    Open Access•David A Wiss, Kristen Criscitelli et al.•ARTICLE•Appetite•2017•Cited by: 2•References: 104

  • Putative Covid- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion

    Kenneth Blum, Jean Lud Cadet et al.•ARTICLE•Substance Use & Misuse•2020

  • Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans

    Open Access•Kenneth Blum, Jag Khalsa et al.•ARTICLE•Frontiers in Psychiatry•2021

    Over years, the regular use of cannabis has substantially increased among young adults, as indicated by the rise in cannabis use disorder (CUD), with an estimated prevalence of 8. 3% in the United States. Research shows that exposure to cannabis is associated with hypodopaminergic anhedonia (depression), cognitive decline, poor memory, inattention, impaired learning performance, reduced dopamine brain response-associated emotionality, and increas…

  • Reward Deficiency Syndrome (RDS)

    Open Access•Kenneth Blum, Abdalla Bowirrat et al.•ARTICLE•International Journal of…•2021

    Alcohol and other substance use disorders share comorbidity with other RDS disorders, i.e., a reduction in dopamine signaling within the reward pathway. RDS is a term that connects addictive, obsessive, compulsive, and impulsive behavioral disorders. An estimated 2 million individuals in the United States have opioid use disorder related to prescription opioids. It is estimated that the overall cost of the illegal and legally prescribed opioid cr…

  • Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (Gars) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic…

    Open Access•Ashim Gupta, Abdalla Bowirrat et al.•ARTICLE•International Journal of…•2022

    In the United States, amid the opioid overdose epidemic, nonaddicting/nonpharmacological proven strategies are available to treat pain and manage chronic pain effectively without opioids. Evidence supporting the long-term use of opioids for pain is lacking, as is the will to alter the drug-embracing culture in American chronic pain management. Some pain clinicians seem to prefer classical analgesic agents that promote unwanted tolerance to analge…

  • High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling

    Open Access•John Tyler, Madeline Podaras et al.•ARTICLE•Frontiers in Public Health•2023

    Background Previous research has outlined the health benefits of exercise including its therapeutic potential for substance use disorders (SUD). These data have already been utilized and it is now common to find exercise as part of SUD treatment and relapse prevention programs. However, we need to better understand different exercise regimens and determine which would be the most beneficial for SUDs. Recently, high intensity interval training (HI…

  • Opioid use disorder

    Open Access•Yu Kyung Lee, Mark S Gold et al.•ARTICLE•Frontiers in Public Health•2024

    Opioid use disorder (OUD) is a major public health threat, contributing to morbidity and mortality from addiction, overdose, and related medical conditions. Despite our increasing knowledge about the pathophysiology and existing medical treatments of OUD, it has remained a relapsing and remitting disorder for decades, with rising deaths from overdoses, rather than declining. The COVID-19 pandemic has accelerated the increase in overall substance …

  • Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia

    Open Access•Kai-Uwe Lewandrowski, Kenneth Blum et al.•ARTICLE•Frontiers in Public Health•2025

    Since 1990, substantial evidence from association studies has identified the D(2) dopamine receptor (DRD2) gene as a factor in the development of alcoholism [1][2][3][4]. The DRD2 gene has also been linked to other substance use disorders, including dependencies on cocaine, nicotine, and opioids, as well as obesity [5][6][7][8][9][10][11]. Dopamine in the brain, often referred to as the "stressrelief molecule," plays a central role in managing st…

  • Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery

    Open Access•Colin Hanna, Fiona Comstock et al.•ARTICLE•Frontiers in Public Health•2025

    The obesity epidemic has become a global public health issue, impacting more than one billion people worldwide. 9% of the US population, or 28.8 million Americans will have an eating disorder in their lifetime. In fact, global eating disorder prevalence increased from 3.5% to 7.8% between 2000 and 2018. In spite of the fact that less than 6% of people with an eating disorder are medically underweight, it is indeed an important factor when conside…

  • The Emerging Crisis in Non-Prescribed Ketamine Use

    Open Access•Kai Uwe Lewandrowski, Kenneth Blum et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: Since 2000, rates of suicide and opioid overdose have sharply increased. Approximately one-third of individuals with major depressive disorder (MDD) experience treatment-resistant depression (TRD), highlighting the urgent need for novel therapeutic approaches. OBJECTIVE: This review synthesizes pivotal preclinical and clinical findings on low-dose ketamine's rapid antidepressant effects and examines proposed mechanisms underlying its …

Medicine (14 works) · Psychiatry (14 works) · Psychology (14 works) · Addiction (11 works) · Dopamine (8 works) · Neurotransmitter Receptor Influence on Behavior (7 works) · Dopaminergic (5 works) · Internal Medicine (5 works) · Neuroscience (5 works) · Developmental psychology (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae